HeartSciences Inc. HSCS
4.73
0.10
2.16%
as of 25 Sep
- Market cap
- $23.9M
- P/E
- 0.0×
Follow HSCS
| Older periods | Oct '25 | Jan '26 | Apr '26 | Jul '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(220.46%) | (382.44%) | (4,252.05%) | (1,854.69%) | |
| (131.22%) | (128.00%) | (192.75%) | (201.67%) | ||
ROIC |
(230.90%) | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(396.32%) | (968.64%) | 408.32% | 214.26% | |
Average Days of Receivables |
0.00 | — | — | 0.00 | |
Free Cash Flow per Share |
(2.71) | (2.34) | (2.85) | (1.94) | |
Free Cash Flow |
(7.54) | (7.39) | (7.47) | (7.12) | |
Capital Expenditures |
(0.04) | (0.05) | (0.04) | (0.32) | |
Piotroski F-Score |
6.00 | — | 2.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(122.25%) | (113.45%) | (394.43%) | 339.07% | |
Accounts Receivable Turnover |
0.00 | — | — | 0.00 | |
Accounts Payable Turnover |
0.02 | 0.00 | 0.01 | 0.00 | |
Inventory Turnover |
0.01 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
18,101.72 | 0.00 | 64,544.17 | 143,585.38 | |
Days of Inventory on Hand |
37,486.64 | 0.00 | 132,941.11 | 56,575.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
16,097.82% | 0.00% | 0.00% | 13,025.59% | |
Selling, General and Administrative Expense of Revenue |
19,904.37% | 0.00% | 0.00% | 31,906.16% | |
Share Based Compensation of Revenue |
3,328.38% | 0.00% | 0.00% | 8,894.31% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.83 | 0.87 | 0.81 | 0.66 | |
Depreciation/Fixed assets |
13.55 | 13.75 | 15.96 | 18.82 | |
Capex/Depreciation |
(0.06) | (0.08) | (0.07) | (0.52) | |
Revenue per Share |
0.01 | 0.00 | 0.00 | 0.01 | |
Operating CF per Share |
(2.70) | (2.32) | (2.83) | (1.85) | |
Capex per Share |
(0.02) | (0.02) | (0.02) | (0.09) | |
Capex to Sales |
1.89 | 0.00 | 0.00 | 15.35 | |
Net Profit Margin |
(39,460.26%) | 0.00% | 0.00% | (48,621.80%) |
Columns are period end dates